Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2005
05/26/2005WO2005047860A2 Antibodies to alpha-synuclein
05/26/2005WO2005047858A2 On-line apparatus and method for determining endotoxin levels
05/26/2005WO2005047854A2 Fiber-optic assay apparatus based on phase-shift interferometry
05/26/2005WO2005047853A2 Apparatus and method for detecting an analyte
05/26/2005WO2005047851A2 Device for measuring nanometer level pattern-dependent binding reactions
05/26/2005WO2005047788A1 Cooler comprising gas sensor
05/26/2005WO2005047546A2 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders
05/26/2005WO2005047544A1 Risk assessment for adverse drug reactions
05/26/2005WO2005047541A1 Oscillating temperature capillary electrophoresis and uses therefor
05/26/2005WO2005047532A1 Improved method of performing genetic analyses on reproductive tract cell samples
05/26/2005WO2005047531A1 Assay for pkc-beta activation of phosphorylation of myosin heavy chain polypeptide
05/26/2005WO2005047530A2 Method for assaying compounds that modulate the activity of protein tyrosine phosphatase receptor zeta (ptprzeta)
05/26/2005WO2005047528A1 Electrode for electrochemical sensors
05/26/2005WO2005047527A1 Electrochemical sensor strip
05/26/2005WO2005047525A1 Methods of validating target for modulating insulin action, screening for modulators of insulin action and therapeutic uses thereof
05/26/2005WO2005047519A2 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas
05/26/2005WO2005047509A2 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
05/26/2005WO2005047502A1 Protein library and screening method using the same
05/26/2005WO2005047500A1 hERG CHANNEL-EXPRESSING CELL
05/26/2005WO2005047492A1 Melanocytes in therapy of neurodegenerative diseases
05/26/2005WO2005047484A2 Biomarkers for alzheimer's disease
05/26/2005WO2005047482A2 Real time electronic cell sensing systems and applications for cell-based assays
05/26/2005WO2005047476A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
05/26/2005WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof
05/26/2005WO2005047326A2 Interleukin-10 antibodies
05/26/2005WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof
05/26/2005WO2005047318A1 Gnal splice variant and uses thereof
05/26/2005WO2005047307A2 Il-18 binding proteins
05/26/2005WO2005047305A2 Cellular membrane protein assay
05/26/2005WO2005047245A2 Fluorescence assays with improved blocking groups
05/26/2005WO2005047242A2 Compounds containing thiosulfate moieties
05/26/2005WO2005047225A1 Method for the detection of thiols in aqueous solution
05/26/2005WO2005046879A1 Separation apparatus and method
05/26/2005WO2005046859A2 System and method for carrying out multiple binding reactions in an array format
05/26/2005WO2005046735A1 A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
05/26/2005WO2005046734A1 Method of identifying responders to treatment with insulin sensitizers
05/26/2005WO2005046731A1 Interference with c-maf function in multiple myeloma
05/26/2005WO2005046724A1 Remedy/preventive for vascular disorders and hypertension and method of screening the same
05/26/2005WO2005046722A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
05/26/2005WO2005046718A1 Diagnosis and hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in pancreas cells (12.1)
05/26/2005WO2005046711A2 Stimulation or inhibition of gamma delta t-cells to promote or inhibit bone healing
05/26/2005WO2005046667A2 System a transport inhibitors for treating or preventing neuropsychiatric disorders
05/26/2005WO2005046619A2 Compositions and methods for modulating c-rel-dependent cytokine production
05/26/2005WO2005046617A2 Compositions and methods for reducing microbial induced apoptosis
05/26/2005WO2005046616A2 Viral propagation system and uses thereof
05/26/2005WO2005046610A2 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter
05/26/2005WO2005046607A2 Combinations for the treatment of proliferative diseases
05/26/2005WO2005046602A2 Vegf receptor antagonists
05/26/2005WO2005046587A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
05/26/2005WO2005046583A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes
05/26/2005WO2005046573A2 Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
05/26/2005WO2005046455A2 Methods for identifying or monitoring a patient with increased risk of cardiovascular calcification
05/26/2005WO2005046452A2 A polypeptide complex that regulates cell cycle and anergy
05/26/2005WO2005046449A2 Soluble tcr molecules and methods of use
05/26/2005WO2005046442A2 Immunosorbent tests for assessing paroxysmal cerebral discharges
05/26/2005WO2005031309A3 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
05/26/2005WO2005030028A3 Methods for detecting presence of cellular constituents
05/26/2005WO2005029073A8 Chromatographic assay device and methods
05/26/2005WO2005026911A3 Apparatus and method for identifying therapeutic targets using a computer model
05/26/2005WO2005026738A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a9 (slc22a9)
05/26/2005WO2005015156A3 Molecular detector
05/26/2005WO2005013077A3 Systems and methods for microarray data analysis
05/26/2005WO2005010048A3 Rg1 antibodies and uses thereof
05/26/2005WO2005009374A8 Ceramide dependent-stabilization of bace1
05/26/2005WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
05/26/2005WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents
05/26/2005WO2005005954A3 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes
05/26/2005WO2005003715A3 Promoted ionization for secondary ion mass spectrometry
05/26/2005WO2005003158A3 Compositions and methods for increasing bone mineralization
05/26/2005WO2004111642A3 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 1 (snsr1)
05/26/2005WO2004110416A3 Use of a cx3c agonist for the treatment of pain and for promoting nerve regeneration
05/26/2005WO2004106941A3 Secreted polypeptide species associated with cardiovascular disorders
05/26/2005WO2004106937A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 6 (p2y6)
05/26/2005WO2004104591A3 Improvements to gamma delta t cell-mediated therapy
05/26/2005WO2004102194A9 Support having selectively bonding substance fixed thereto
05/26/2005WO2004102156A3 Compositional modeling and pyrolysis data analysis methods
05/26/2005WO2004099784A3 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
05/26/2005WO2004099772A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr1a (agtr1a)
05/26/2005WO2004097372A9 Element-coded affinity tags
05/26/2005WO2004089975A3 Peptides of irf-1
05/26/2005WO2004089526A8 Methods of providing product consistency
05/26/2005WO2004089421A3 Methods for rational pegylation of proteins
05/26/2005WO2004079339A3 Target ligand generation
05/26/2005WO2004073486B1 Diagnostic device and method
05/26/2005WO2004068105A8 Immunoassay and method of use
05/26/2005WO2004061126A3 Nucleic acid hybridization assay using bridging sequence
05/26/2005WO2004027028A3 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
05/26/2005WO2004025248A3 Antibody pair screening methods
05/26/2005WO2003077841A3 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
05/26/2005WO2003048730A3 Identification of high affinity molecules by limited dilution screening
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050114912 Model for neurodegenerative disorders
05/26/2005US20050114062 Method of reducing the effect of direct interference current in an electrochemical test strip
05/26/2005US20050114060 On-line fluid monitoring that compensates for a fluid's temperature dependance
05/26/2005US20050114040 Information processing system using nucleotide sequence-related information
05/26/2005US20050114037 generating polymeric attachment sites on target proteins comprising inputting coordinates into computers for the target protein and using simulation modules on said coordinates to create a set of amino acid positions of said protein suitable for polymeric attachment; modification of therapeutic proteins
05/26/2005US20050114035 Method for binding site identification
05/26/2005US20050113717 Devices for physiological fluid sampling and methds of using the same
05/26/2005US20050113662 Magnetic sensor and method for analysing a fluid
05/26/2005US20050113658 Fiber optic device for sensing analytes and method of making same
1 ... 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 ... 3937